HEALTHCARE | Medical Devices & Equipment / Surgical Devices
See what CB Insights has to offer
Series C - IV | Alive
$1.5M | 22 yrs ago
Researcher and developer of a minimally invasive, encapsulated cellular transplant device for the treatment of diabetes. The company sold its assets to Novocell.
Neocrin Headquarter Location
31 Technology Drive Suite 100
Irvine, California, 92618,
Predict your next investment
The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.
Expert Collections containing Neocrin
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Neocrin is included in 1 Expert Collection, including Diabetes.